Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy
- PMID: 33569355
- PMCID: PMC7868542
- DOI: 10.3389/fcimb.2020.608402
Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy
Abstract
Multidrug-resistant (MDR) organisms have increased worldwide, posing a major challenge for the clinical management of infection. Bacteriophage is expected as potential effective therapeutic agents for difficult-to-treat infections. When performing bacteriophage therapy, the susceptibility of lytic bacteriophage to the target bacteria is selected by laboratory isolate from patients. The presence of a subpopulation in a main population of tested cells, coupled with the rapid development of phage-resistant populations, will make bacteriophage therapy ineffective. We aimed to treat a man with multifocal urinary tract infections of MDR Klebsiella pneumoniae by phage therapy. However, the presence of polyclonal co-infectious cells in his renal pelvis and bladder led to the failure of three consecutive phage therapies. After analysis, the patient was performed with percutaneous nephrostomy (PCN). A cocktail of bacteriophages was selected for activity against all 21 heterogeneous isolates and irrigated simultaneously via the kidney and bladder to eradicate multifocal colonization, combined with antibiotic treatment. Finally, the patient recovered with an obviously improved bladder. The success of this case provides valuable treatment ideas and solutions for phage treatment of complex infections.
Clinical trial registration: www.chictr.org.cn, identifier ChiCTR1900020989.
Keywords: heterogeneous cells; multidrug-resistant Klebsiella pneumoniae; percutaneous nephrostomy; phage therapy; urinary tract infection.
Copyright © 2021 Qin, Wu, Bao, Shi, Ou, Ye, Zhao, Wei, Cai, Li, Guo, Weng, Lu, Tan, Zhang, Huang, Zhu, Shi, Hu, Guo and Zhu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Corbellino M., Kieffer N., Kutateladze M., Balarjishvili N., Leshkasheli L., Askilashvili L., et al. (2019). Eradication of a multi-drug resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom-made, lytic bacteriophage preparation. Clin. Infect. Dis. An Off. Publ. Infect. Dis. Soc. America 70 (9), 1998–2001. 10.1093/cid/ciz782 - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
